Harrell Investment Partners’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,613
Closed -$247K 131
2025
Q1
$247K Sell
3,613
-1,703
-32% -$139K 0.07% 88
2024
Q4
$413K Sell
5,316
-8,158
-61% -$604K 0.12% 75
2024
Q3
$903K Buy
13,474
+1,356
+11% +$111K 0.26% 65
2024
Q2
$1.37M Buy
12,118
+682
+6% +$86.2K 0.4% 63
2024
Q1
$1.59M Buy
+11,436
New +$1.44M 0.47% 55

Other funds holding DXCM

Harrell Investment Partners's DXCM Position: Q2 2025 in Review

Harrell Investment Partners sold out of DexCom (DXCM) in Q2 2025, closing a stake of 3,613 shares — an estimated $247K sold.

Harrell Investment Partners first reported a position in DXCM in Q1 2024 and held it in 5 quarters. The position peaked at $1.59M in Q1 2024. 939 funds tracked by Wall St. Rank hold DXCM as of Q2 2025.

  • Harrell Investment Partners reported no remaining DexCom position as of Q2 2025 after selling out during the quarter.
  • Harrell Investment Partners sold 3,613 DexCom shares in Q2 2025, an estimated $247K.
  • Harrell Investment Partners first reported a position in DexCom in Q1 2024 and held it in 5 quarters.
  • Harrell Investment Partners's DexCom position peaked at $1.59M in Q1 2024.
  • 939 funds tracked by Wall St. Rank held DexCom as of Q2 2025.

Based on Harrell Investment Partners's 13F filing for Q2 2025, filed 15 Jul 2025.